Skip to main content
. 2022 May 29;31:101286. doi: 10.1016/j.bbrep.2022.101286

Table 6.

Nucleotide mutations of HPV16 and tumor progression.

Mutations <CIN2 ≥CIN2 χ2 P OR 95% CI P
A4 843T 8 27 9.197 0.004* 0.111 0.024–0.520 0.005*
A4 843C 8 3
A1 666G 15 17 1.456 0.180 2.059 0.631–6.712 0.722
A1 666A 6 14
A4 7287A 7 18 7.887 0.07* 0.097 0.016–0.576 0.010*
A4 7287C 8 2
A4 7418A 12 12 1.591 0.281 2.667 0.566–12.557 0.215
A4 7418G 3 8
A4 7780C 3 8 1.591 0.281 0.375 0.08–1.766 0.215
A4 7780T 12 12
A4 7872A 10 19 4.844 0.040* 0.105 0.011–1.029 0.053
A4 7872G 5 1
A1 7711T 17 20 3.272 0.095 4.25 0.816–22.132 0.086
A1 7711G 2 10

Note: *P < 0.05.